From July 2003 through October 2004, 42 patients became infected by strains of Leuconostoc mesenteroides subsp. mesenteroides (genotype 1) in different departments of Juan Canalejo Hospital in northwest Spain. During 2006, 6 inpatients, also in different departments of the hospital, became infected (genotypes 2-4).
View Article and Find Full Text PDFPosaconazole (POS) and caspofungin (CAS) are new therapeutic options for treating fungal infection. This study establishes the activity of POS and CAS against yeast causing invasive fungal infections. In addition, the utility of the E-test system for estimating the minimum inhibitory concentrations (MICs) related to these antifungal drugs has been assessed.
View Article and Find Full Text PDF